S

Shanghai MicroPort MedBot Group Co Ltd
HKEX:2252

Watchlist Manager
Shanghai MicroPort MedBot Group Co Ltd
HKEX:2252
Watchlist
Price: 30.96 HKD -1.34%
Market Cap: HK$31.9B

Shanghai MicroPort MedBot Group Co Ltd
Revenue

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Shanghai MicroPort MedBot Group Co Ltd
Revenue Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
S
Shanghai MicroPort MedBot Group Co Ltd
HKEX:2252
Revenue
¥551.1m
CAGR 3-Years
194%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
A
APT Medical Inc
SSE:688617
Revenue
¥2.6B
CAGR 3-Years
29%
CAGR 5-Years
40%
CAGR 10-Years
N/A
J
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SZSE:002223
Revenue
¥7.9B
CAGR 3-Years
0%
CAGR 5-Years
2%
CAGR 10-Years
13%
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
Revenue
¥33.3B
CAGR 3-Years
3%
CAGR 5-Years
10%
CAGR 10-Years
N/A
Andon Health Co Ltd
SZSE:002432
Revenue
¥1.6B
CAGR 3-Years
-61%
CAGR 5-Years
-3%
CAGR 10-Years
16%
Shanghai United Imaging Healthcare Co Ltd
SSE:688271
Revenue
¥10.3B
CAGR 3-Years
12%
CAGR 5-Years
28%
CAGR 10-Years
N/A
No Stocks Found

Shanghai MicroPort MedBot Group Co Ltd
Glance View

Market Cap
31.9B HKD
Industry
Health Care

Shanghai MicroPort MedBot Group Co Ltd is a dynamic player in the medical innovation sector, strategically positioned at the crossroads of advanced technology and healthcare. Born out of a vision to revolutionize surgical practices, MedBot has dedicated itself to the development and commercialization of robotic-assisted systems. The company leverages cutting-edge research and development to create robotic platforms that aid surgeons in performing complex procedures with enhanced precision and control. Operating in a field where precision is paramount, MedBot's products are designed to minimize complications and reduce recovery times, catering to a global demand for improved surgical outcomes. MedBot generates its revenue by selling these sophisticated surgical robots to hospitals and healthcare institutions worldwide. Beyond the initial sale, the company benefits from offering ongoing service contracts, training, and support to ensure seamless integration and optimal performance of their products. Additionally, it capitalizes on the sale of consumables and replacement parts required for the long-term operation of their systems. Through its commitment to innovation and focus on addressing the complexities of surgical procedures, Shanghai MicroPort MedBot Group has carved out a distinctive niche, continually expanding its influence within the expanding scope of minimally invasive surgery.

Intrinsic Value
6.51 HKD
Overvaluation 79%
Intrinsic Value
Price HK$30.96
S

See Also

What is Shanghai MicroPort MedBot Group Co Ltd's Revenue?
Revenue
551.1m CNY

Based on the financial report for Dec 31, 2025, Shanghai MicroPort MedBot Group Co Ltd's Revenue amounts to 551.1m CNY.

What is Shanghai MicroPort MedBot Group Co Ltd's Revenue growth rate?
Revenue CAGR 3Y
194%

Over the last year, the Revenue growth was 114%. The average annual Revenue growth rates for Shanghai MicroPort MedBot Group Co Ltd have been 194% over the past three years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett